Hancock Jaffe Laboratories Incの内部者の所有権

Hancock Jaffe Laboratories Incの内部者の所有権は何ですか。

Hancock Jaffe Laboratories Incの内部者の所有権は12.67%です。

内部者の所有権の定義は何ですか。



管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー(5%超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

NASDAQのセクタHealth Careにおける内部者の所有権の企業と比べるHancock Jaffe Laboratories Inc

Hancock Jaffe Laboratories Incは何をしますか。

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

Hancock Jaffe Laboratories Incと類似の内部者の所有権